Nathalie Rolhion

机构：Inserm, Sorbonne Université, Assistance Publique – Hôpitaux de Paris, Hôpital Saint-Antoine, Fédération Hospitalo-Universitaire, Paris Center for Microbiome Medicine, Centre de Recherche Saint-Antoine · ORCID：0000-0002-2946-4808

发表论文 92 篇 · 总被引 4481 次 · h-index 33

代表论文

• Microbiota in neuroinflammation and synaptic dysfunction: a focus on Alzheimer’s disease (2022 · Molecular Neurodegeneration · 被引 322)
• Rewiring the altered tryptophan metabolism as a novel therapeutic strategy in inflammatory bowel diseases (2022 · Gut · 被引 257)
• Butyrate acts through HDAC inhibition to enhance aryl hydrocarbon receptor activation by gut microbiota-derived ligands (2022 · Gut Microbes · 被引 142)
• Human CD4+CD8α+ Tregs induced by Faecalibacterium prausnitzii protect against intestinal inflammation (2022 · JCI Insight · 被引 88)
• AhR/IL-22 pathway as new target for the treatment of post-infectious irritable bowel syndrome symptoms (2022 · Gut Microbes · 被引 87)
• Faecalibacterium prausnitzii strain EXL01 boosts efficacy of immune checkpoint inhibitors (2024 · OncoImmunology · 被引 72)